Centre for Design and Synthesis of Molecularly Targeted Radiopharmaceuticals (CERAD)
2020.07.07 - admin2 Over 2,500 m2 of research and infrastructure space, worth nearly PLN 117 million, is being built in the nuclear center in Świerk. The investment is carried out as part of a project co-financed by the European Union called Centrum Projektowania i Synetezy Radiofarmaceutyków Ukierunkowanych Molekularnie – CERAD (Design and synthesis of molecularly targeted radiopharmaceuticals – Centrum CERAD).
2019.05.20 - Marek Pawłowski Between 13th and 17th of May the second meeting on coordinating research of new 99mTc production methods and 99mTc generators was held in Świerk as a part of the programme of the International Atomic Energy Agency. Guests from several countries from five continents have discussed various aspects related to satisfying the needs of patients all over the world for this basic isotope in nuclear medicine.